Nanwei Medical shareholders approve 2025 profit distribution, audit firm

Nanwei Medical Technology Co. Ltd. held its second extraordinary general meeting of shareholders for 2025 on August 27, 2025, in Nanjing. All proposed resolutions, including the 2025 half-year profit distribution plan and the appointment of the 2025 audit firm, were approved without objection. A total of 153 shareholders and proxies, representing 104,032,451 voting rights or 55.6545% of the company's total voting rights, participated in the meeting.

The proposal for the 2025 half-year profit distribution plan received 99.9829% of votes in favor from common shareholders, with 104,014,750 votes. The appointment of the 2025 audit firm also passed with significant support, garnering 99.9888% of common shareholder votes, totaling 104,020,892 votes. Both resolutions were ordinary resolutions and successfully passed with more than half of the votes cast by attending shareholders.

The meeting ensured separate tabulation of votes from small and medium investors for both key proposals. Jiangsu Xingao Law Firm, represented by attorneys Zhang Yihong and Zhang Mei, confirmed that the meeting's convening, procedures, and resolutions complied with company law and relevant regulations, affirming the legality and effectiveness of the decisions made.